Suzano S.A. (SUZB3)
Sao Paulo Exchange · Brazil · prices in BRL · close of 16 Oct 2026
Key indicators
| Last close | BRL 43.05 |
|---|---|
| 52-week range | 39.17 – 59.64 |
| Return, 1 month / 3 months | −7.8% / +2.7% |
| Return, 1 year / 3 years | −8.6% / −15.3% |
| Trend | Below its 200-day average |
| RSI (14) | 44 |
| Volatility (1 year) | 29.0% |
| Worst drawdown (1 year) | -32.7% |
| Average daily value traded | 305.10M BRL |
| Dividend yield | 2.6% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Suzano is a Brazilian pulp and paper company based in Sao Paulo. It produces eucalyptus hardwood pulp, which it supplies to customers around the world, and it also makes paper products including tissue, printing and writing papers, and packaging materials. Its operations cover planted forests, pulp mills and paper mills, and its customers include converters, printers and consumer goods companies in Brazil and abroad.
The shares are listed on the Sao Paulo Exchange in Brazil under the code SUZB3, and the price on this page is in Brazilian reais (BRL). Our dividend records, which start in 2019, show payments in 6 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Suzano S.A. (SUZB3) trades on the Sao Paulo Exchange in Brazil. It last closed at BRL 43.05 on 16 October 2026.
Its price-based Market X-Ray is 53 out of 100 (a fair price profile), ranking 695 of 1,454 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 8.6% and over the last three months it rose 2.7%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Sao Paulo Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 32 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -7.7% | ||
| From 52-week high | -27.0% | ||
| Momentum | 41 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | 2.7% | ||
| 6-month return | -9.4% | ||
| 12-month return, skipping the last month | -0.9% | ||
| Stability (higher is calmer) | 62 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 29.0% | ||
| Worst drawdown, 1 year (smaller is calmer) | -32.7% | ||
| Liquidity | 99 · Strong | Trades actively. | |
| Average daily value traded | 305.10M BRL | ||
| Zero-volume days | 0.0% | ||
| Income | 41 · Weak | Dividend is small or irregular. | |
| Dividend yield | 2.6% | ||
| Years with dividends | 5 |
Strengths
- Liquidity: Trades actively.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
- Income: Dividend is small or irregular.
Returns
| 1 week | +0.7% |
|---|---|
| 1 month | −7.8% |
| 3 months | +2.7% |
| 6 months | −9.4% |
| 1 year | −8.6% |
| 3 years | −15.3% |
| 5 years | – |
Signals
| 50-day / 200-day average | 44.63 / 46.63 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 1.21 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 29 Apr 2026 | BRL 0.0046 |
| 18 Dec 2025 | BRL 1.1166 |
| 16 Dec 2024 | BRL 2.0174 |
| 7 Dec 2023 | BRL 1.1634 |
| 16 Dec 2022 | BRL 1.7948 |
| 4 May 2022 | BRL 0.5928 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Sao Paulo Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.